TROD Medical

TROD Medical is a Paris-based company that specializes in innovative medical solutions, focusing on the development and delivery of advanced healthcare technologies aimed at enhancing patient outcomes. Founded in 2006, TROD Medical operates as an independent entity based in Paris, France. The company focuses on the development of medical technologies to improve healthcare delivery. It previously underwent strategic pivots to refine its product offerings.

The firm has participated in 4 deals, with its latest funding round being a Series B that concluded in October 2013, raising EUR 4. 75 mn. This round was co-led by Capricorn Partners and Vesalius Biocapital, with participation from K. U.

Leuven Research & Development and PMV - ParticipatieMaatschappij Vlaanderen NV. The total amount raised by the company stands at EUR 4. 75 mn. TROD Medical specializes in innovative solutions through its core product offerings, which include advanced software platforms designed for enterprise resource management and customer relationship management.

These products streamline operational processes, enhance data analytics capabilities, and facilitate seamless communication across departments. The company addresses the primary end-use cases of improving productivity and optimizing resource allocation for businesses in various sectors, enhancing overall operational efficiency. Their products have been adopted by a diverse client base, including small to medium-sized enterprises and larger corporations across North America and Europe, particularly in tech-driven industries, healthcare providers, and retail businesses. TROD Medical generates revenue through a structured transaction model based on subscription-based services, where clients pay recurring fees for access to their software solutions.

This model facilitates predictable revenue streams as customers enter long-term contracts for essential services. The company's flagship software solutions are bundled into tiered pricing plans that cater to varying client needs, from basic service packages to comprehensive enterprise solutions, accommodating different levels of user access and feature sets. This strategic approach fosters customer loyalty and partnerships with resellers and integrators that enhance the reach of the company's products. TROD Medical is focused on developing new products to meet evolving healthcare needs, with plans to release several innovative solutions by 2024.

The company aims to expand its market presence in Europe and North America, specifically targeting Germany and the United Kingdom by the end of 2024. The recent funding of EUR 4. 75 mn raised in October 2013 will be utilized to support these initiatives, enhancing product development and market entry strategies.